SARS-Related Coronavirus 2 Stock

NATtrol™ SARS-CoV-2 external run controls are designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 RNA. NATSARS(COV2)-ERC and NATSARS(COV2)-NEG enable laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and can provide assistance in identifying random or systemic error.

WARNINGS AND PRECAUTIONS:

  • NATtrol™ inactivation was carried out on SARS-Cov-2 stock used to formulate the controls. The inactivation was verified in a standard microbiological growth protocol.
  • This product contains inactivated microorganisms and materials of human and animal origin. Safe practices suggest that the controls be considered potentially infectious and to use Universal Precautions when handling. • Refer to CDC guidelines and local regulations for handling and disposal.
  • The matrix used in the manufacture of this product is treated with 0.09% sodium azide. It was manufactured from Human Serum Albumin that has been tested and found to be non-reactive at the donor level for HIV-1/HIV[1]2 Antibody, HBsAg and HCV Antibody by FDA licensed donor screening test methods. All materials are also tested for HIV-1 and HCV by FDA approved Nucleic Acid Test (NAT) methods.
  • Heat inactivated Fetal Bovine Serum used in the manufacture of this product meets applicable USDA requirements for abattoir sourced animals, traceability and country of origin. The materials were collected at USDA licensed establishments or legally imported from countries recognized by the USDA as negligible or controlled for risk for Bovine Spongiform Encephalopathy (BSE) and other exotic disease agents. Donor animals were inspected ante and post mortem at the abattoir as required by the USDA.
  • Do not use past the expiration date on the label.
  • To avoid cross-contamination, use separate pipette tips for all materials.
SARS Coronavirus antibody

Leave a Comment